Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

MT newswire2026/10/09 13:12

09:12 AM EDT, 10/09/2026 (MT Newswires) -- Outlook Therapeutics (OTLK) said Friday it has promoted Greg DiPasquale to chief commercial officer. DiPasquale, who joined the company in December 2025 as head of commercial for Lytenava, will now lead all commercial functions, the company said. Prior to joining Outlook, DiPasquale was senior vice president and head of commercial at specialty pharmaceutical company Harrow (HROW), where he led the commercial organization for its ophthalmic pharmaceutical portfolio. Shares of the company were up 2% pre-bell.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The central bank has increased its gold reserves for 24 consecutive months, with October’s increase hitting a record high for the period.

新浪财经•2026/11/09 05:37

Trader Gu Jingci: November 9 Bitcoin/Ethereum Trading Strategy and Market Analysis

AiCoin•2026/11/09 05:35

Dow Jones Top Energy Headlines at 12 AM ET: Oil Futures Slide As Market Holds Out Hopes for Middle East Diplomacy | Energy ...

Dow Jones•2026/11/09 05:00

United States Dollar Index remains subdued as lower oil prices ease inflation pressure

FXStreet•2026/11/09 04:54